Citadel Advisors
LMAT icon

Citadel Advisors’s LeMaitre Vascular LMAT Stock Holding History

Citadel Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$317K Buy
2,900
+200
+7% +$19.1K ﹤0.01% 10360
2025
Q4 		$219K Buy
+2,700
New +$232K ﹤0.01% 10847
2025
Q2 		– Sell
-400
Closed -$33.6K – 13961
2025
Q1 		$33.6K Sell
400
-2,500
-86% -$233K ﹤0.01% 12704
2024
Q4 		$267K Hold
2,900
– – ﹤0.01% 9890
2024
Q3 		$269K Buy
2,900
+2,000
+222% +$173K ﹤0.01% 9547
2024
Q2 		$74.1K Sell
900
-1,900
-68% -$140K ﹤0.01% 11301
2024
Q1 		$186K Buy
2,800
+2,200
+367% +$136K ﹤0.01% 10433
2023
Q4 		$34.1K Buy
600
+200
+50% +$10.5K ﹤0.01% 12152
2023
Q3 		$21.8K Sell
400
-300
-43% -$17.8K ﹤0.01% 12563
2023
Q2 		$47.1K Sell
700
-900
-56% -$54.9K ﹤0.01% 11869
2023
Q1 		$82.4K Buy
+1,600
New +$77.7K ﹤0.01% 11518
2022
Q1 		– Sell
-6,600
Closed -$332K – 14161
2021
Q4 		$332K Buy
+6,600
New +$341K ﹤0.01% 10703
2021
Q3 		– Sell
-4,400
Closed -$268K – 14292
2021
Q2 		$268K Buy
+4,400
New +$234K ﹤0.01% 11535

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Citadel Advisors's LMAT Position: Q1 2026 in Review

Citadel Advisors increased its LeMaitre Vascular (LMAT) stake by 546% in Q1 2026, buying an estimated $7.82M and bringing the position to 97,083 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3168.

Citadel Advisors first reported a position in LMAT in Q4 2015 and has held it in 37 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Citadel Advisors held 97,083 shares of LeMaitre Vascular worth $10.6M as of Q1 2026.
  • Citadel Advisors bought 82,047 LeMaitre Vascular shares in Q1 2026, an estimated $7.82M.
  • LeMaitre Vascular made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3168 holding.
  • Citadel Advisors first reported a position in LeMaitre Vascular in Q4 2015 and has held it in 37 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.